(Q39231935)

10 September 2017

title

Transcatheter Closure of Intracardiac Shunts (English)

1 reference

10 September 2017

David T. Balzer

1

1 reference

10 September 2017

publication date

1 October 2004

1 reference

Current treatment options in cardiovascular medicine

10 September 2017

published in

1 reference

10 September 2017

volume

6

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

417-422

1 reference

Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale

10 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-004-0025-4

Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder

21 January 2018

1 reference

12 December 2020

Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators

1 reference

12 December 2020

Surgically remediable complications of myocardial infarction

1 reference

12 December 2020

Secundum atrial septal defect. Nonoperative closure during cardiac catheterization

1 reference

12 December 2020

Device closure of ventricular septal defects

1 reference

12 December 2020

Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant

1 reference

12 December 2020

Contemporary management of patent foramen ovale

1 reference

12 December 2020

Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm

1 reference

12 December 2020

Transcatheter closure of post-myocardial infarction ventricular septal defect with Amplatzer septal occluder

1 reference

12 December 2020

Transcatheter closure of ventricular septal defects: hemodynamic instability and anesthetic management.

1 reference

12 December 2020

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

1 reference

12 December 2020

Initial human experience with the Amplatzer perimembranous ventricular septal occluder device

1 reference

12 December 2020

Cost implications of closure of atrial septal defect

1 reference

12 December 2020

Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry

1 reference

12 December 2020

Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies

1 reference

12 December 2020

Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.

1 reference

12 December 2020

Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations.

1 reference

12 December 2020

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study

1 reference

12 December 2020

Incidence of congenital heart disease in children born to residents of Olmsted County, Minnesota, 1950-1969

1 reference

12 December 2020

Prospective comparison of costs and short term health outcomes of surgical versus device closure of atrial septal defect in children

1 reference

12 December 2020

Early and late complications associated with transcatheter occlusion of secundum atrial septal defect

1 reference

12 December 2020

Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients

1 reference

12 December 2020

Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients

1 reference

12 December 2020

10.1007/S11936-004-0025-4

Identifiers

DOI

1 reference

10 September 2017

1 reference